Диссертация (Качество жизни и респираторная функция у пациентов, излеченных от туберкулеза легких), страница 36

– 2008. –Vol. 32. – N. 3. – P. 637-643.283314. Qaseem A, Wilt TJ, Weinberger SE, Hanania NA, Criner G, van derMolen T, Marciniuk DD, Denberg T, Schünemann H, Wedzicha W,MacDonald R, Shekelle P; American College of Physicians; AmericanCollege of Chest Physicians; American Thoracic Society; EuropeanRespiratory Society. Diagnosis and management of stable chronicobstructive pulmonary disease: a clinical practice guideline update from theAmerican College of Physicians, American College of Chest Physicians,American Thoracic Society, and European Respiratory Society.

// AnnIntern Med. – 2011. – Vol. 155. – N. 3. – P. 179-191.315. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, YernaultJC. Lung volumes and forced ventilatory flows. Report Working PartyStandardization of Lung Function Tests, European Community for Steeland Coal. Official Statement of the European Respiratory Society. // EurRespir J. – 1993. - Vol.

6. – N.1. - P. 5-40.316. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis,management, and prevention of chronic obstructive pulmonary disease:GOLD executive summary // Am J Respir Crit. Care Med. - 2007. - Vol.176. - N.6. – P.

532-555.317. Radovic M, Ristic L, Stankovic I, Pejcic T, Rancic M, Ciric Z, DinicRadovic V. Chronic airflow obstruction syndrome due to pulmonarytuberculosis treated with directly observed therapy--a serious changes inlung function. // Med Arh.

– 2011. – Vol. 65. – N. 5. – P. 265-269.318. Ralph AP, Kenangalem E, Waramori G, Pontororing GJ, Sandjaja,Tjitra E, Maguire GP, Kelly PM, Anstey NM. High morbidity duringtreatment and residual pulmonary disability in pulmonary tuberculosis:under-recognised phenomena. // PLoS One. – 2013. – Vol. 8. – N. 11. – P.e80302.284319.

Redelmeier DA, Bayoumi AM, Goldstein RS, and Guyatt GH.Interpreting small differences in functional status: the Six Minute Walk testin chronic lung disease patients. // Am J Respir Crit Care Med. - 1997. Vol. 155. - N.4. - P. 1278-1282.320. Ries AL, Kaplan RM, Limberg TM, Prewitt LM. Effects of pulmonaryrehabilitation on physiologic and psychosocial outcomes in patients withchronic obstructive pulmonary disease.

// Ann Intern Med. – 1995. – Vol.122. –N. 11. – P. 823-832.321. Ross J, Ehrlich RI, Hnizdo E, White N, Churchyard GJ. Excess lungfunction decline in gold miners following pulmonary tuberculosis. //Thorax. – 2010. – Vol. 65. – N. 11. – P. 1010-1015.322. Ruppel GL. What is the clinical value of lung volumes? // Respir Care. –2012.

– Vol. 57. – N. 1. – P. 26-35.323. Salhi B, Troosters T, Behaegel M, Joos G, Derom E. Effects ofpulmonary rehabilitation in patients with restrictive lung diseases. // Chest.– 2010. – Vol. 137. – N. 2. – P. 273-279.324. Salvi SS, Barnes PJ. Chronic obstructive pulmonary disease in nonsmokers.

// Lancet. – 2009. – vol. 374. – N. 9691. – P. 733-743.325. Schünemann HJ, Dorn J, Grant BJ, Winkelstein W Jr, Trevisan M.Pulmonary function is a long-term predictor of mortality in the generalpopulation: 29-year follow-up of the Buffalo Health Study. // Chest. –2000. – Vol. 118. – N. 3. – P. 656-664.326. Singh SJ, Sodergren SC, Hyland ME, Williams J, Morgan MD. Acomparison of three disease-specific and two generic health-statusmeasures to evaluate the outcome of pulmonary rehabilitation in COPD. //Respir Med. – 2001. – Vol. 95. – N. 1. – P. 71-77.327. Shoup R, Dalsky G, Warner S, Davies M, Connors M, Khan M, Khan F,ZuWallack R.

Body composition and health-related quality of life in285patients with obstructive airways disease. // Eur Respir J. – 1997. – Vol. 10.– N. 7. – P. 1576-1580.328. Sin DD, Wu L, Man SF. The relationship between reduced lung functionand cardiovascular mortality: a population-based study and a systematicreview of the literature. // Chest. – 2005. – Vol. 127. – N. 6. – P. 1952-9.329. Singh S.

Walking for the assessment of patients with chronic obstructivepulmonary disease. // Eur Respir Mon. – 2007. – Vol. 40. - P. 148-164.330. Singh SJ, Puhan MA, Andrianopoulos V, Hernandes NA, Mitchell KE,Hill CJ, Lee AL, Camillo CA, Troosters T, Spruit MA, Carlin BW, WangerJ, Pepin V, Saey D, Pitta F, Kaminsky DA, McCormack MC, MacIntyre N,Culver BH, Sciurba FC, Revill SM, Delafosse V, Holland AE. An officialsystematic review of the European Respiratory Society/American ThoracicSociety: measurement properties of field walking tests in chronicrespiratory disease. // Eur Respir J. – 2014.

– Vol.44. – N.6. – P.1447-1478.331.Smith BM, Hoffman EA, Basner RC, Kawut SM, Kalhan R, Barr RG.Not all measures of hyperinflation are created equal: lung structure andclinical correlates of gas trapping and hyperexpansion in COPD: the MultiEthnic Study of Atherosclerosis (MESA) COPD Study. // Chest. – 2014. –Vol.145. – N.6. – P.1305-1315.332.

Snider GL, Doctor L, Demas TA, Shaw AR. Obstructive airway diseasein patients with treated pulmonary tuberculosis. // Am Rev Respir Dis. 1971. - Vol. 103. – N. 5. - P. 625-640.333. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematicoverview of the measurement properties of functional walk tests used in thecardiorespiratory domain.

// Chest. – 2001. – Vol. 119. – N.1. - P. 256-270.334. Sood A, Beckett WS. Determination of disability for patients withadvanced lung disease. // Clin Chest Med. – 1997. - Vol. 18. – N. 3. P.471-482.286335. Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, HillK, Holland AE, Lareau SC, Man WD, Pitta F, Sewell L, Raskin J,Bourbeau J, Crouch R, Franssen FM, Casaburi R, Vercoulen JH, VogiatzisI, Gosselink R, Clini EM, Effing TW, Maltais F, van der Palen J, TroostersT, Janssen DJ, Collins E, Garcia-Aymerich J, Brooks D, Fahy BF, PuhanMA, Hoogendoorn M, Garrod R, Schols AM, Carlin B, Benzo R, Meek P,Morgan M, Rutten-van Mölken MP, Ries AL, Make B, Goldstein RS,Dowson CA, Brozek JL, Donner CF, Wouters EF; ATS/ERS Task ForceonPulmonaryRehabilitation.AnofficialAmericanThoracicSociety/European Respiratory Society statement: key concepts andadvances in pulmonary rehabilitation. // Am J Respir Crit Care Med.

–2013. – Vol. 188. – N. 8. – P. e13-64.336. Streiner DL, Norman GR. Mine is bigger than yours: Measures of effectsize in research. // Chest. – 2012. – Vol.141. – N.3. – P.595-598.337. Swanney MP, Beckert LE, Frampton CM, Wallace LA, Jensen RL,Crapo RO. Validity of the American Thoracic Society and otherspirometric algorithms using FVC and forced expiratory volume at 6 s forpredicting a reduced total lung capacity.

// Chest. – 2004. – Vol. 126. – N.6. – P. 1861-1866.338. Tian J, Zhou Y, Cui J, Wang D, Wang X, Hu G, Tian Y, Jiang Y, ZhengJ, Wang J, Zhong N, Ran P. Peak expiratory flow as a screening tool todetect airflow obstruction in a primary health care setting. // Int J TubercLung Dis. – 2012. – Vol. 16. – N. 5. – P. 674-680.339. Tockman MS, Comstock GW.

Respiratory risk factors and mortality:longitudinal studies in Washington County, Maryland. // Am Rev RespirDis. – 1989. – Vol. 140. – N. 3 Pt 2. – P. S56-63.340. Troosters T, Gosselink R, Decramer M. Six minute walking distance inhealthy elderly subject.

// Eur Respir J. – 1999. - Vol. 14. – N. 2. - P. 270274.287341.Troosters T, Vilaro J, Rabinovich R, Casas A, Barberà JA, RodriguezRoisin R, Roca J. Physiological responses to the 6-min walk test in patientswith chronic obstructive pulmonary disease. // Eur Respir J. – 2002.

– Vol.20. – N. 3. – P. 564-569.342. Troosters T, Demeyer H, Hornikx M, Camillo CA, Janssens W.Pulmonary rehabilitation. // Clin Chest Med. – 2014. – Vol.35. – N.1. –P.241-249.343. Vandevoorde J, Verbanck S, Schuermans D, Broekaert L, Devroey D,Kartounian J, Vincken W.

Forced vital capacity and forced expiratoryvolume in six seconds as predictors of reduced total lung capacity. // EurRespir J. – 2008. – Vol. 31. – N. 2. – P. 391-395.344. Van Schayck CP, Loozen JM, Wagena E, Akkermans RP, Wesseling GJ.Detecting patients at a high risk of developing chronic obstructivepulmonary disease in general practice: cross sectional case finding study.

//BMJ. – 2002. – Vol. 324. – N. 7350. – P. 1370-1374.345. van Schayck CP, Halbert RJ, Nordyke RJ, Isonaka S, Maroni J, NonikovD. Comparison of existing symptom-based questionnaires for identifyingCOPD in the general practice setting. // Respirology. – 2005. – Vol. 10. –N. 3. – P. 323-333.346. van Zyl Smit RN, Pai M, Yew WW, Leung CC, Zumla A, Bateman ED,Dheda K.

Global lung health: the colliding epidemics of tuberculosis,tobacco smoking, HIV and COPD. // Eur Respir J. – 2010. – Vol. 35. – N.1. – P. 27-33.347. Venkateshiah SB, Ioachimescu OC, McCarthy K, Stoller JK. The utilityof spirometry in diagnosing pulmonary restriction. // Lung. – 2008. – Vol.186. – N. 1. – P. 19-25.348.Verrill D, Barton C, Beasley W, Lippard WM. The effects of short-termand long-term pulmonary rehabilitation on functional capacity, perceived288dyspnea, and quality of life. // Chest. – 2005. – Vol. 128. – N. 2. – P. 673683.349. Vestbo J.

COPD: Definition and Phenotypes. // Clin Chest Med. – 2014.– Vol.35. – N.1. – P. 1-6.350. Wang ML, Avashia BH, Petsonk EL. Interpreting periodic lung functiontests in individuals: the relationship between 1- to 5-year and long-termFEV1 changes. // Chest. – 2006. – Vol. 130. – N. 2. – P. 493-499.351.

Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F,Casaburi R, Crapo R, Enright P, van der Grinten CP, Gustafsson P,Hankinson J, Jensen R, Johnson D, Macintyre N, McKay R,Miller MR,Navajas D, Pellegrino R, Viegi G. Standardisation of the measurement oflung volumes. // Eur Respir J. – 2005. – Vol. 26.